Rachna Shroff: Pioneering Oncologist Dies at 47 After Cancer Battle
Dr. Rachna Shroff, a prominent Indian-American oncologist, passed away at 47 after a courageous fight against cancer, leaving behind a legacy in cancer research.
Dr. Shroff was a leading expert in rare bile duct cancers.
She contributed significantly to cancer research and education.
Despite her illness, she established a fund to support future cancer researchers.
Dr. Rachna Shroff, a distinguished Indian-American oncologist known for her expertise in rare bile duct cancers, has passed away at the age of 47 after a prolonged battle with cancer. Her death was confirmed by the University of Arizona, where she held significant academic and clinical roles, including associate director of clinical investigations at the Arizona Cancer Center.
Born into a family of medical professionals, Dr. Shroff was raised in Tucson, Arizona. Her mother, Amita Trivedi, was a nephrologist, and her father, Devendar Trivedi, was a biochemist. This scientific upbringing fostered her passion for medicine and research, which she pursued vigorously throughout her career in the United States. Dr. Shroff was not only recognized for her clinical work but also for her cultural contributions, including performances with a Bollywood dance troupe in Texas.
Dr. Shroff's academic journey began with a biochemistry degree from Brown University, followed by a medical degree from Thomas Jefferson University. She completed her medical oncology fellowship at the University of Texas MD Anderson Cancer Center and remained on its faculty until 2018. Over her career, she published over 80 scientific papers and presented at more than 130 professional conferences, significantly impacting the field of oncology.
Her dedication to cancer research remained unwavering, even as she faced her own diagnosis. In September, she initiated the Conquer Cancer–Rachna Shroff FASCO Endowed Young Investigator Award, which raised over $1.35 million to support researchers focused on biliary cancers. This initiative exemplifies her commitment to advancing treatment options in a field where choices have historically been scarce.
Dr. Shroff's passing leaves a profound impact on the medical community and the future of cancer research. Her efforts to enhance clinical trial access in southern Arizona and her leadership roles in various oncology committees will continue to influence the next generation of oncologists. As the community mourns her loss, her legacy will inspire ongoing advancements in cancer treatment and research.
